InsidersTradesSigma
한미사이언스 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 한미사이언스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 한미사이언스 has recorded 202 public disclosures. Market capitalisation: €2,434.3bn. The latest transaction was disclosed on 7 July 2026 (Purchase). Among the most active insiders: 임종훈. The full history is accessible without an account.
202
Insider Decl.
n/a
Thresholds
n/a
45 ops.
Buy Volume
€281m
34 ops.
Sell Volume
33Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,877 of 27,969 companies
52.3
score / 100
Value46
Quality59
FCF yld1.1%
Earn yld4.9%
EV/EBITDA17.3x
ROE15%
Gross mgn23%
Net mgn8.7%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations202 total
25 of 202 declarations
About 한미사이언스
Hanmi Science is a South Korean company focused on the health and pharmaceutical sector. It is listed on the XKRX market.